XYMOFLAM SP TABLET is a combination of Diclofenac, Paracetamol and Serratiopeptidase which belongs to the group of medicines called Nonsteroidal Anti-inflammatory Drugs (NSAID), Analgesics and Anti-pyrectics. It is used to relieve symptoms such as fever, pain and inflammation associated with musculoskeletal and joint disorders.
XYMOFLAM SP TABLET is not recommended for use in patients with asthma (aspirin sensitive asthma), urticaria or acute rhinitis precipitated by aspirin or other NSAIDs, severe liver disease or kidney disease, severe congestive heart failure, ischemic heart disease (heart attack), blockages of blood vessels to the heart and in patients with history or active peptic ulcer, bleeding (blood in stools, vomiting blood) or perforation or active gastrointestinal bleeding.
XYMOFLAM SP TABLET should be used with caution in patients with pre-existing asthma, seasonal allergic rhinitis, nasal polyps, chronic obstructive pulmonary disease or chronic infections of the respiratory tract, mild to moderate congestive heart failure and high blood pressure.
XYMOFLAM SP TABLET is not recommended for use in children. It should be used with caution in elderly patients (aged 65 years or above). Consult your doctor before taking XYMOFLAM SP TABLET.
The most common side effects of taking XYMOFLAM SP TABLET are nausea, vomiting, stomach pain, diarrhoea, indigestion, flatulence and gastritis. Consult your physician if any of the side effects worsen during or after treatment with XYMOFLAM SP TABLET.
XYMOFLAM SP TABLET helps to treat pain, where Diclofenac inhibits COX-1 and COX-2 and blocks the production of prostaglandins (which are responsible for pain), while paracetamol works by decreasing fever by acting on the hypothalamus (heat-regulation centre in the brain) produces peripheral vasodilation, resulting in increased blood flow through the skin, sweating and heat loss. It also increases the pain threshold by inhibiting COX-1 and COX-2 enzymes and serratiopeptidase is an anti-inflammatory agent which reduces inflammation and swelling in the affected area. It also breaks abnormal proteins at the site of inflammation and promotes healing. Together, relieves fever and pain effectively.
Take XYMOFLAM SP TABLET as advised by your physician. Swallow XYMOFLAM SP TABLET with a glass of water. Do not crush or chew the medicine. Your doctor will decide the correct dose and duration of XYMOFLAM SP TABLET for you depending upon your age, body weight and disease condition.
Stop taking XYMOFLAM SP TABLET and contact your physician immediately if you experience any of the following side effects:
Eat fibre rich foods such as fresh fruits, vegetables and cereals. Drink more water and exercise regularly. Consult your doctor if constipation did not improve.
Drink lot of fluids such as water or fruit juices to keep yourself hydrated. Do not take any medicine on your own for treating diarrhoea. Consult your doctor if diarrhoea does not improve.
Rest and relax. Drink plenty of fluids such as water or electrolytes and apply a pain-relieving balm on the forehead if necessary. Do not consume alcohol. Consult your doctor if headache worsens.
Take XYMOFLAM SP TABLET with or just after meals. Stick to simple meals. Avoid eating oily, spicy or fried foods. Consult your doctor if nausea and vomiting does not improve.
Rest and relax. Eat and drink slowly or try to have smaller and frequent meals. Keep a heat pad on your stomach. Do not self-treat on your own and consult your doctor if the symptom does not improve.
XYMOFLAM SP TABLET is generally not recommended for use during pregnancy and in women planning for pregnancy. Consult your doctor before taking XYMOFLAM SP TABLET.
XYMOFLAM SP TABLET is not recommended for use in breastfeeding women as it may pass through the breast milk. Consult your doctor before taking XYMOFLAM SP TABLET.
Do not drive or operate any machines if you experience dizziness or drowsiness after taking XYMOFLAM SP TABLET.
Avoid consumption of alcohol while taking XYMOFLAM SP TABLET as it may lead to unwanted effects.
XYMOFLAM SP TABLET is not recommended for use in patients with severe kidney disease. It should be used with caution in patients with impaired kidney function. Consult your doctor before taking XYMOFLAM SP TABLET.
XYMOFLAM SP TABLET is not recommended for use in patients with severe liver disease. It should be used with caution in patients with impaired liver function. Consult your doctor before taking XYMOFLAM SP TABLET.
Do not take XYMOFLAM SP TABLET if you are either allergic to diclofenac, paracetamol, serratiopeptidase, acetylsalicylic acid, misoprostol or other NSAIDs such as ibuprofen, naproxen.
XYMOFLAM SP TABLET is not recommended for use in patients with asthma (aspirin sensitive asthma), acute rhinitis precipitated by aspirin or other NSAIDs and should be used with caution in patients with pre-existing asthma, seasonal allergic rhinitis, nasal polyps, chronic obstructive pulmonary diseases or chronic infections of the respiratory tract. Consult your doctor before taking XYMOFLAM SP TABLET.
XYMOFLAM SP TABLET is not recommended for use in patients with severe congestive heart failure, ischemic heart disease (heart attack), blockages of blood vessels to the heart and in the setting of coronary artery bypass graft surgery (CABG). It should be used with caution in patients with impaired cardiac function, mild to moderate congestive heart failure and high blood pressure. Consult your doctor before taking XYMOFLAM SP TABLET.
XYMOFLAM SP TABLET is not recommended for use in children. Consult your child’s doctor for advice.
XYMOFLAM SP TABLET should be used with caution in elderly patients (aged 65 years or above). Consult your doctor before taking XYMOFLAM SP TABLET.
XYMOFLAM SP TABLET is not recommended for use if you have:
Before taking XYMOFLAM SP TABLET, inform your doctor if you have:
A. Drug-Drug interactions:
Before taking XYMOFLAM SP TABLET, inform your doctor if you are taking any of the following medicines:
Overdosage:
If you or anyone else accidentally take too much of XYMOFLAM SP TABLET, consult your doctor immediately or visit the nearby hospital. Overdosage symptoms of XYMOFLAM SP TABLET includes headache, nausea, vomiting, diarrhoea, epigastric pain, gastrointestinal bleeding, dizziness, disorientation, excitation, coma, drowsiness, tinnitus, fainting, occasionally convulsions, acute kidney failure and liver damage.
Drug | : | Diclofenac, Paracetamol and Serratiopeptidase |
Pharmacological Category | : | Nonsteroidal Anti-inflammatory Drugs, Analgesics and Anti-pyrectics |
Therapeutic Indication | : | Relieves fever, pain and inflammation |
Dosage Forms | : | Tablet |
What is XYMOFLAM SP TABLET and why is it prescribed?
XYMOFLAM SP TABLET is a combination of Diclofenac, Paracetamol and Serratiopeptidase which belongs to the group of medicines called Nonsteroidal Anti-inflammatory Drugs (NSAID), Analgesics and Anti-pyrectics. It is used to relieve symptoms such as fever, pain and inflammation associated with musculoskeletal and joint disorders.
What are the common side effects of taking XYMOFLAM SP TABLET?
The most common side effects of taking XYMOFLAM SP TABLET are nausea, vomiting, stomach pain, diarrhoea, indigestion, ulcers in the stomach or intestines, bleeding/perforation, heartburn, etc. Consult your physician if any of the side effects worsen.
Does XYMOFLAM SP TABLET cause bleeding?
Yes, XYMOFLAM SP TABLET may increase the risk of bleeding, ulceration and perforation in stomach and intestine and it is not recommended for use in patients with history or active gastric or intestinal ulcer, bleeding (blood in stools, vomiting blood) or perforation. Consult your doctor before taking XYMOFLAM SP TABLET.
Can XYMOFLAM SP TABLET be used in patients with liver problems?
XYMOFLAM SP TABLET is not recommended for use in patients with severe liver disease. It should be used with caution in patients with impaired liver function. Consult your doctor before taking XYMOFLAM SP TABLET.
Is XYMOFLAM SP TABLET safe to use in pregnant women?
No, XYMOFLAM SP TABLET is generally not recommended for use during pregnancy and in women planning for pregnancy. Consult your doctor for advice before taking this medicine if you are pregnant or planning to get pregnant.
1. K.D. Tripathi. NSAIDs and Antipyretic-Analgesics. Essentials of medical pharmacology. Seventh edition. 2013. Page – 204, 206.
2. Bethesda (MD). Diclofenac. National Institute of Health. NLM. National Centre for Biotechnology Information. PubChem Compound Summary. 2004. [Accessed on 27th June 2022] https://pubchem.ncbi.nlm.nih.gov/compound/3033
3. Bethesda (MD). Paracetamol. National Institute of Health. NLM. National Centre for Biotechnology Information. PubChem Compound Summary. 2004. [Accessed on 27th June 2022] https://pubchem.ncbi.nlm.nih.gov/compound/1983
4. Cipla Ltd. Cipzen-d-plus (Diclofenac, Paracetamol and Serratiopeptidase). Ciplamed. [Revised in January 2020] [Accessed on 2nd July 2022] https://www.ciplamed.com/content/cipzen-d-plus-tablets
5. Painwell-SP. (Diclofenac, Paracetamol and Serratiopeptidase). Wellona Pharma. [Accessed on 2nd July 2022] https://wellonapharma.com/product/finished/diclofenac-potassium-paracetamol-and-serratiopeptidase-tablets
6. Volvib-Plus. (Diclofenac, Paracetamol and Serratiopeptidase). Vibcare. [Accessed on 2nd July 2022] https://vibcare.co.in/diclofenac-paracetamol-serratiopeptidase/
Written By Dr. R. Dinesh John Rajkumar, Pharm.D
Last updated on 24 Feb 2023 | 06:31 PM(IST)
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.